GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (OTCPK:HTSUF) » Definitions » Total Equity

Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Total Equity : $1,785.1 Mil (As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Total Equity?

Hisamitsu Pharmaceutical Co's total equity for the quarter that ended in Feb. 2024 was $1,785.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Hisamitsu Pharmaceutical Co Total Equity Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Total Equity Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,278.85 2,408.53 2,211.05 1,942.21 1,785.09

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,942.21 1,908.94 1,900.14 1,813.83 1,785.09

Hisamitsu Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Hisamitsu Pharmaceutical Co's Total Equity for the fiscal year that ended in Feb. 2024 is calculated as

Total Equity=Total Assets(Q: Feb. 2024 )-Total Liabilities(Q: Feb. 2024 )
=2197.5-412.412
=1,785.1

Hisamitsu Pharmaceutical Co's Total Equity for the quarter that ended in Feb. 2024 is calculated as

Total Equity=Total Assets(Q: Feb. 2024 )-Total Liabilities(Q: Feb. 2024 )
=2197.5-412.412
=1,785.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Headlines

No Headlines